A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL)

Published

Conference Paper

Full Text

Link to Item

Duke Authors

Cited Authors

Gururangan, S; Grant, G; Driscoll, T; Archer, G; Herndon, J; Friedman, H; Kurtzberg, J; Bigner, D; Sampson, J; Mitchell, D

Published Date

April 1, 2013

Published In

Neuro Oncology

Volume / Issue

15 /

Start / End Page

46 - 47

Published By

OXFORD UNIV PRESS INC

Pages

2

International Standard Serial Number (ISSN)

1522-8517

Conference Name

2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference

Conference Location

Fort Lauderdale, FL

Conference Start Date

May 16, 2013

Conference End Date

May 17, 2013